Study links molecular testing to indeterminate thyroids

A report highlighted in Cancer Cytopathology says implementing molecular testing for thyroid nodules has been associated with an increase in indeterminate (AUS/FLUS) diagnoses in some settings. The observation was presented as an implementation effect rather than a simple assay performance claim. (x.com)